Navigation Links
PETA International Science Consortium disappointed in denial of Dow appeal
Date:6/19/2013

The PETA International Science Consortium (PISC) is extremely disappointed that the European Chemicals Agency (ECHA) Board of Appeal has upheld a decision that requires Dow Benelux B.V.to conduct a pre-natal developmental toxicity study in rats. The study will use approximately 1160 animals and expose pregnant rats and their unborn pups to the substance dipropylene glycol methyl ether acetate (DPMA) in order to comply with the European Community's Regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).

PISC urges the Board of Appeal to demonstrate greater independence when making decisions regarding the justification of read-across arguments in future appeal cases.

The substance DPMA hydrolyses to dipropylene glycol methyl ether (DPM), for which data are already available. In an appeal filed on January 24, 2012, the company rightfully argued that the testing requirement was, therefore, satisfied using read-across arguments.

The Board of Appeal's decision means that pregnant rats will be forced to consume high concentrations of the chemical over a 16 day period before being killed and their offspring, dissected. Read-across arguments are a mechanism by which large numbers of animal tests can be avoided which makes this decision even more disappointing as it may unjustifiably discourage other chemical manufacturers from using valid read-across arguments which could ultimately lead to hundreds of thousands of additional animals being used. As many as ten million animals could be used in testing conducted for REACH.

The European Ombudsman is currently considering a complaint submitted by PETA in July 2012 alleging that ECHA is failing to ensure that animal testing is conducted only as a "last resort," as required by the REACH regulation.


'/>"/>

Contact: Gilly Stoddart
GillyS@peta.org.uk
44-207-837-6327
People for the Ethical Treatment of Animals
Source:Eurekalert

Page: 1

Related biology news :

1. First international collaboration to showcase latest body of evidence of dairy health benefits
2. SPIE on global team proposing International Year of Light at United Nations
3. CLEO: 2013 -- the Premier International Laser and Electro-Optics Event in San Jose next week
4. New review sets international standards for best practice in fracture liaison services
5. BGI hosts its 2nd International Conference on Genomics in the Americas
6. Drive-Up Biometric System from SRI International Sarnoff Wins New Product Showcase Award at ISC West 2013
7. International conference will put agri-food supply chain under the microscope
8. International collaboration to investigate disappearing reptiles and amphibians
9. International conference to tackle climate-change threats to agriculture
10. International study: Excess dietary salt may drive the development of autoimmune diseases
11. International consortium builds Google Map of human metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
Breaking Biology Technology: